Tactile Medical Q1 revenue $48.0M (+12% YoY); net loss $15.6M vs $2.3M loss YoY

TACTILE SYSTEMS TECHNOLOGY INC

2022-Q1 EPS reported -$0.78 revenue$47,978,000

Revenue $48.0M (+12% YoY); net loss $15.6M ($0.78 diluted EPS) vs $2.3M ($0.12) in Q1 2021.
Operating loss $14.9M vs $4.1M YoY; non-GAAP operating loss $5.4M vs $3.1M.
Adjusted EBITDA loss $2.6M vs $7K loss YoY.
Reaffirmed FY2022 revenue guidance $235M-$240M (13-15% growth).
Airway clearance product line contributed $7.3M revenue; lymphedema product line declined 5%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.